Kiniksa Pharma Signs Deal
Kiniksa Pharmaceuticals enters material definitive agreement, files 8-K with SEC. Financial statements and exhibits included.
Filed: 2026-05-26 AccNo: 0001730430-26-000025 Size: 241 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits